Jason Evans, Milton W. Datta, Mary Goolsby, Peter Langenstroer

Canadian Journal of Urology, Vol.12, No.3, pp. 2722-2723, 2005

Abstract Eccrine porocarcinoma, an uncommon carcinoma of the sweat glands, rarely arises from the male genitalia. In past reports this presentation has been associated with Paget’s disease. This is the first known report of eccrine porocarcinoma of the scrotum unassociated with Paget’s disease. More >

A. H. Feifer, B. C. Fong, L. Feldman, G. Fried, L. A. Stein, P. Metrakos, S. Bergman, M. Anidjar

Canadian Journal of Urology, Vol.12, No.3, pp. 2713-2721, 2005

Abstract Objective: To assess the efficacy of CT angiography (CTA) in evaluating the renovascular anatomy in 50 patients who underwent laparoscopic donor nephrectomy, and to correlate results with donor morbidity and recipient outcome.
Methods: Forty-eight patients were evaluated by CTA prior to laparoscopy. Donors with aberrant renovasculature and their respective recipients were divided into: 1) accurate preoperative CTA ("predictive group", PG), 2) inaccurate CTA ("non-predictive group", NPG). Warm ischemia times (WIT), estimated blood loss (EBL), operative time (OT), and the open conversion rate were compared. Recipient creatinine values on post-operative day 1 and 3 months were recorded with… More >

Neil T. Dwyer, Thomas F. Whelan

Canadian Journal of Urology, Vol.12, No.3, pp. 2710-2712, 2005

Abstract Splenosis should be considered in the differential of any patient with a history of splenic trauma or removal and a solid enhancing mass near or within the kidney. Splenosis is the autotransplantation of splenic tissue associated with splenic trauma or surgery, and can be diagnosed properatively, avoiding unnecessary surgery. More >

Howard H. Pai^1,2, Francis Lau²

Canadian Journal of Urology, Vol.12, No.3, pp. 2700-2709, 2005

Abstract Introduction: Providing men with prostate cancer (MPC) timely access to their health records and information (HRI) can enhance their ability to understand their condition and engage in shared medical decision making with their health care provider (HCP). The Internet is a potential means of enhancing such interactions.
Materials and methods: Two surveys were conducted at a PC support group in Victoria, BC to identify the health information needs of MPC and the ability to access their HRI. Another objective was to identify the potential role of web-enabled HRI systems at meeting these needs. Sixty-one participants (41 men… More >

Luc Valiquette¹, Francesco Montorsi², Wayne J. G. Hellstrom³, Francois Giuliano⁴, Martin Homering⁵, Terry Taylor⁶, Ian Eardley⁷

Canadian Journal of Urology, Vol.12, No.3, pp. 2687-2698, 2005

Abstract Objective: To assess success rates in ability to penetrate (Sexual Encounter Profile question 2 [SEP2]) and maintain erections to completion of intercourse (SEP3) from time of dosing to start of sexual activity in a retrospective analysis of two pivotal trials.
Methods: In two randomized, double-blind studies, men with ED for >6 months received vardenafil 5 mg, 10 mg, or 20 mg or placebo for 12-26 weeks. Patients were instructed to start sexual activity 1 hour after dosing. In this retrospective pooled analysis, patient diary questions through week 12 were analyzed, providing attempt data was recorded 0-12 hours… More >

J. Curtis Nickel¹, Sender Herschorn², Jacques Corcos², Bryan Donnelly¹, Doug Drover², Mostafa Elhilali¹, Larry Goldenberg¹, John Grantmyre², Bruno Laroche², Richard Norman¹, Bruce Piercy¹, Karen Psooy², Gary Steinhoff¹, John Trachtenberg¹, Fred Saad¹, Simon Tanguay¹

Canadian Journal of Urology, Vol.12, No.3, pp. 2677-2683, 2005

Abstract Objective: To develop the first Canadian guidelines for the management of lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH).
Methods: These guidelines, developed under a mandate provided by the Canadian Urological Association (CUA), were a collaborative effort between the CUA guidelines committee and the Canadian Prostate Health Council. BPH guidelines developed by the American Urological Association, the European Association of Urology, the World Health Organization International Consultation on BPH, and similar committees from Germany, Sweden and Australia were reviewed. The committee further reviewed a systematic literature search, updated to May 2004, and systematically derived… More >

Uzair B. Chaudhary¹, Mohammad H. Rashid¹, Adedayo A. Onitilo², Nabil K. Bissada³

Canadian Journal of Urology, Vol.12, No.3, pp. 2666-2676, 2005

Abstract Prostate cancer is a heterogeneous disease and clinical outcomes vary considerably after failure of primary androgen ablation. With the development of new therapeutics the management of patients with androgen independent prostate cancer has changed considerably over the last few years. Multiple secondary hormonal manipulations are available and may lead to prolonged periods of clinical response. These maneuvers include the use of oral antiandrogens, antiandrogen withdrawal, ketoconazole, aminoglutethimide, corticosteroids and use of estrogenic compounds. This article reviews the clinical activity of these agents in management of patients with advanced prostate cancer. More >

Laurence H. Klotz

Canadian Journal of Urology, Vol.12, No.3, pp. 2616-2617, 2005

Abstract This article has no abstract. More >

A. K. Pelletier, P. A. M. Anderson, R. D. Schwarz

Canadian Journal of Urology, Vol.12, No.4, pp. 2774-2777, 2005

Abstract Introduction: Endoscopic techniques are becoming increasingly accepted for treatment of vesicoureteric reflux as alternatives to open surgical reimplantation. However, there is some debate about the ideal injectable material. Since we have accumulated experience with several substances, an opportunity existed to compare them.
Materials and methods: From 1991 to 2003, 101 children with vesicoureteric reflux were treated by endoscopic subureteric injection either once (74) or twice (27) by either of two pediatric urologists. There were a total of 165 ureteral injections, 83 with polytetrafluoroethylene (Teflon®), 73 with polydimethylsiloxane (Macroplastique®), and 9 with collagen. Each child was evaluated pre-operatively… More >

Mohammad Al-Omar¹, Kevin Kwan¹, Edward Tweedie², Patrick P. W. Luke¹

Canadian Journal of Urology, Vol.12, No.4, pp. 2772-2773, 2005

Abstract Aggressive angiomyxoma is a rare locally invasive non-metastasizing soft tissue neoplasm that is most commonly located in the female pelvis and perineum. We report a case of aggressive angiomyxoma arising from the epididymis of a young male, which was treated by radical orchiectomy. More >